Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · IEX Real-Time Price · USD
5.51
+0.02 (0.36%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Ardelyx Employees
Ardelyx had 267 employees as of December 31, 2023. The number of employees increased by 134 or 100.75% compared to the previous year.
Employees
267
Change (1Y)
134
Growth (1Y)
100.75%
Revenue / Employee
$595,918
Profits / Employee
-$246,487
Market Cap
1.29B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 267 | 134 | 100.75% |
Dec 31, 2022 | 133 | 47 | 54.65% |
Dec 31, 2021 | 86 | -43 | -33.33% |
Dec 31, 2020 | 129 | 41 | 46.59% |
Dec 31, 2019 | 88 | 2 | 2.33% |
Dec 31, 2018 | 86 | 11 | 14.67% |
Dec 31, 2017 | 75 | -18 | -19.35% |
Dec 31, 2016 | 93 | 32 | 52.46% |
Dec 31, 2015 | 61 | 27 | 79.41% |
Dec 31, 2014 | 34 | 20 | 142.86% |
Dec 31, 2013 | 14 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Omnicell | 3,650 |
Establishment Labs Holdings | 908 |
ANI Pharmaceuticals | 642 |
Gyre Therapeutics | 593 |
Arcus Biosciences | 577 |
Immatics | 535 |
Sana Biotechnology | 328 |
Ocular Therapeutix | 267 |
ARDX News
- 4 days ago - Ardelyx sues US health department over kidney disease drug - Reuters
- 4 days ago - Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines - GlobeNewsWire
- 19 days ago - ARDX Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Ardelyx, Inc. for Potential Securities Law Violations - GlobeNewsWire
- 19 days ago - To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA - GlobeNewsWire
- 23 days ago - Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines - GlobeNewsWire
- 7 weeks ago - Ardelyx, Inc. Reports Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults - GlobeNewsWire